Functional involvement of RFVT3/SLC52A3 in intestinal riboflavin absorption

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 2, 2014, Pages

  Yoshimatsu, Hiroki ^a   Yonezawa, Atsushi ^a   Yao, Yoshiaki ^a   Sugano, Kumiko ^a   Nakagawa, Shunsaku ^a   Omura, Tomohiro ^a   Matsubara, Kazuo ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Intestine; Transporter; Vitamin B2

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; MESSENGER RNA; METHYLENE BLUE; RIBOFLAVIN; RIBOFLAVIN TRANSPORTER 3; SMALL INTERFERING RNA; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ILEUM; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SODIUM DEPLETION;

INTESTINE; TRANSPORTER; VITAMIN B2;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELLS, CULTURED; HEK293 CELLS; HUMANS; ILEUM; IN SITU HYBRIDIZATION; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MEMBRANE TRANSPORT PROTEINS; METHYLENE BLUE; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RIBOFLAVIN; RNA, MESSENGER; TRANSFECTION;

EID: 84892583885     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00349.2013     Document Type: Article

References (34)

1. Anand G, Hasan N, Jayapal S, Huma Z, Ali T, Hull J, Blair E, McShane T, Jayawant S. Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome. Dev Med Child Neurol 54: 187-189, 2012.
2. +/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat. Gastroenterology 127: 1410-1422, 2004.
3. Bates CJ. Bioavailability of riboflavin. Eur J Clin Nutr 51, Suppl 1: S38-S42, 1997.
4. Bosch AM, Abeling NG, Ijlst L, Knoester H, van der Pol WL, Stroomer AE, Wanders RJ, Visser G, Wijburg FA, Duran M, Waterham HR. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis 34: 159-164, 2011.
5. Bosch AM, Stroek K, Abeling NG, Waterham HR, Ijlst L, Wanders RJ. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives (Abstract). Orphanet J Rare Dis 7: 83, 2012.
6. Casirola D, Gastaldi G, Ferrari G, Kasai S, Rindi G. Riboflavin uptake by rat small intestinal brush border membrane vesicles: a dual mechanism involving specific membrane binding. J Membr Biol 135: 217-223, 1993.
7. Ciccolella M, Catteruccia M, Benedetti S, Moroni I, Uziel G, Pantaleoni C, Chiapparini L, Bizzi A, D'Amico A, Fattori F, Salsano ML, Pastore A, Tozzi G, Piemonte F, Bertini E. Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study. Neuromuscul Disord 22: 1075-1082, 2012.
8. Daniel H, Rehner GI. Sodium-dependent transport of riboflavin in brush border membrane vesicles of rat small intestine is an electrogenic process. J Nutr 122: 1454-1461, 1992.
9. Daniel H, Wille U, Rehner G. In vitro kinetics of the intestinal transport of riboflavin in rats. J Nutr 113: 636-643, 1983.
10. Foraker AB, Khantwal CM, Swaan PW. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv Drug Deliv Rev 55: 1467-1483, 2003.
11. Fujimura M, Yamamoto S, Murata T, Yasujima T, Inoue K, Ohta KY, Yuasa H. Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption. J Nutr 140: 1722-1727, 2010.
12. Green P, Wiseman M, Crow YJ, Houlden H, Riphagen S, Lin JP, Raymond FL, Childs AM, Sheridan E, Edwards S, Josifova DJ. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet 86: 485-489, 2010.
13. Jusko WJ, Levy G. Absorption, metabolism, and excretion of riboflavin-5-phosphate in man. J Pharm Sci 56: 58-62, 1967.
14. + exchange activity. Pflugers Arch 445: 139-146, 2002.
15. Levy G, Jusko WJ. Factors affecting the absorption of riboflavin in man. J Pharm Sci 55: 285-289, 1966.
16. Middleton HM, 3rd. Uptake of riboflavin by rat intestinal mucosa in vitro. J Nutr 120: 588-593, 1990.
17. Nishihara K, Masuda S, Nakagawa S, Yonezawa A, Ichimura T, Bonventre JV, Inui K. Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats. Am J Physiol Renal Physiol 298: F923-F934, 2010.
18. Powers HJ. Riboflavin (vitamin B2), health. Am J Clin Nutr 77: 1352-1360, 2003.
19. Rivlin RS. Riboflavin metabolism. N Engl J Med 283: 463-472, 1970.
20. Said HM, Arianas P. Transport of riboflavin in human intestinal brush border membrane vesicles. Gastroenterology 100: 82-88, 1991.
21. Said HM, Mohammadkhani R. Uptake of riboflavin across the brush border membrane of rat intestine: regulation by dietary vitamin levels. Gastroenterology 105: 1294-1298, 1993.
22. Said HM, Mohammadkhani R, McCloud E. Mechanism of transport of riboflavin in rabbit intestinal brush border membrane vesicles. Proc Soc Exp Biol Med 202: 428-434, 1993.
23. Sathasivam Brown S. Vialetto-Van Laere syndrome (Abstract). Orphanet J Rare Dis 3: 9, 2008.
24. Sato T, Masuda S, Yonezawa A, Tanihara Y, Katsura T, Inui K. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1. Biochem Pharmacol 76: 894-903, 2008.
25. Shirasaka Y, Li Y, Shibue Y, Kuraoka E, Spahn-Langguth H, Kato Y, Langguth P, Tamai I. Concentration-dependent effect of naringin on intestinal absorption of 1-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res 26: 560-567, 2009.
26. Subramanian VS, Rapp L, Marchant JS, Said HM. Role of cysteine residues in cell surface expression of the human riboflavin transporter-2 (hRFT2) in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 301: G100-G109, 2011.
27. Subramanian VS, Subramanya SB, Rapp L, Marchant JS, Ma TY, Said HM. Differential expression of human riboflavin transporters-1,-2, and-3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. Biochim Biophys Acta 1808: 3016-3021, 2011.
28. Terada T, Sawada K, Saito H, Hashimoto Y, Inui K. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am J Physiol Gastrointest Liver Physiol 276: G1435-G1441, 1999.
29. Thwaites DT, Kennedy DJ, Raldua D, Anderson CM, Mendoza ME, Bladen CL, Simmons NL. H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger. Gastroenterology 122: 1322-1333, 2002.
30. Yamamoto S, Inoue K, Ohta KY, Fukatsu R, Maeda JY, Yoshida Y, Yuasa H. Identification and functional characterization of rat riboflavin transporter 2. J Biochem 145: 437-443, 2009.
31. Yao Y, Yonezawa A, Yoshimatsu H, Masuda S, Katsura T, Inui K. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J Nutr 140: 1220-1226, 2010.
32. Yao Y, Yonezawa A, Yoshimatsu H, Omura T, Masuda S, Matsubara K. Involvement of riboflavin transporter RFVT2/Slc52a2 in hepatic homeostasis of riboflavin in mice. Eur J Pharmacol 714: 281-287, 2013.
33. Yonezawa A, Inui K. Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52. Mol Aspects Med 34: 693-701, 2013.
34. Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol 295: C632-C641, 2008.